Cargando…
Desloratadine and depression, a drug safety signal based on worldwide spontaneous reporting of side effects
Objective: Desloratadine, a third-generation antihistamine, is claimed to cause fewer central nervous system (CNS) adverse drug reactions (ADRs) than antihistamines of the first- and second-generation. While literature is inconclusive regarding the possible CNS effects, symptoms like somnolence and...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198223/ https://www.ncbi.nlm.nih.gov/pubmed/30084285 http://dx.doi.org/10.1080/03009734.2018.1489918 |